Abstract
Delayed deterioration associated with vasospasm (DDAV) after subarachnoid hemorrhage (SAH), (often called vasospasm) continues to be both a difficult entity to treat and a leading cause of morbidity in patients. Until recently, attention was focused on alleviating the vascular spasm. Recent evidence shows that vascular spasm may not account for all the morbidity of DDAV. There is renewed interest in looking for other potential targets for therapy. Inflammation has become a promising area of research for new treatments. This review explores the evidence that inflammation is a driver of DDAV by asking three questions: (1) If inflammation is important in the pathogenesis of the disease, what part or parts of the inflammatory response are involved? (2) When does inflammation occur in SAH? (3) In what compartment of the skull does the inflammation occur, the cerebrospinal fluid and meninges, the cerebral arteries, or the brain itself?
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81:1–5
Chaichana KL, Levy AP, Miller-Lotan R, Shakur S, Tamargo RJ (2007) Haptoglobin 2–2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage. Stroke 38:3266–3271
Clark JF, Reilly M, Sharp FR (2002) Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: a contributor to subarachnoid hemorrhage-induced vasospasm. J Cereb Blood Flow Metab 22:472–478
Clark JF, Sharp FR (2006) Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 26:1223–1233
Clatterbuck RE, Gailloud P, Ogata L, Gebremariam A, Dietsch GN, Murphy KJ, Tamargo RJ (2003) Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg 99:376–382
Clatterbuck RE, Oshiro EM, Hoffman PA, Dietsch GN, Pardoll DM, Tamargo RJ (2002) Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats. J Neurosurg 97:676–682
Crompton MR (1964) The pathogenesis of cerebral infarction following the rupture of cerebral berry aneurysms. Brain 87:491–510
Delves PJ, Roitt IM (2000) The immune system. N Engl J Med 343:37–49
Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, Castro L, Lusis AJ, Nauseef WM, White CR, Freeman BA (2002) Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296:2391–2394
Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL (2011) Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 31:1443–1451
Eugenin EA, Eckardt D, Theis M, Willecke K, Bennett MV, Saez JC (2001) Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha. Proc Natl Acad Sci USA 98:4190–4195
Fassbender K, Schneider S, Bertsch T, Schlueter D, Fatar M, Ragoschke A, Kuhl S, Kischka U, Hennerici M (2000) Temporal profile of release of interleukin-1beta in neurotrauma. Neurosci Lett 284:135–138
Gaetani P, Tartara F, Pignatti P, Tancioni F, Rodriguez y Baena R, De Benedetti F (1998) Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 20:337–342
Gallia GL, Tamargo RJ (2006) Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurol Res 28:750–758
Gao J, Wang H, Sheng H, Lynch JR, Warner DS, Durham L, Vitek MP, Laskowitz DT (2006) A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit Care 4:25–31
Gentleman SM, Leclercq PD, Moyes L, Graham DI, Smith C, Griffin WST, Nicoll JAR (2004) Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 146:97–104
Haley EC Jr, Kassell NF, Torner JC, Truskowski LL, Germanson TP (1994) A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 80:788–796
Handa Y, Kabuto M, Kobayashi H, Kawano H, Takeuchi H, Hayashi M (1991) The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model. Neurosurgery 28:542–549
Hansen-Schwartz J (2004) Cerebral vasospasm: a consideration of the various cellular mechanisms involved in the pathophysiology. Neurocrit Care 1:235–246
Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, Zhang JH (2007) Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci 28:252–256
Hendryk S, Jarzab B, Josko J (2004) Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuroendocrinol Lett 25:141–147
Hughes JT, Schianchi PM (1978) Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 48:515–525
Iuliano BA, Pluta RM, Jung C, Oldfield EH (2004) Endothelial dysfunction in a primate model of cerebral vasospasm. J Neurosurg 100:287–294
Khurana VG, Fox DJ, Meissner I, Meyer FB, Spetzler RF (2006) Update on evidence for a genetic predisposition to cerebral vasospasm. Neurosurg Focus 21:E3
Kikuchi T, Okuda Y, Kaito N, Abe T (1995) Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage. Neurol Res 17:106–108
Kwan AL, Solenski NJ, Kassell NF, Lee KS (1997) Inhibition of nitric oxide generation and lipid peroxidation attenuates hemolysate-induced injury to cerebrovascular endothelium. Acta Neurochir (Wien) 139:240–247
Ma CX, Yin WN, Cai BW, Wu J, Wang JY, He M, Sun H, Ding JL, You C (2009) Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage. Chin Med J (Engl) 122:1575–1581
Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A, CONSCIOUS-1 Investigators (2008) Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39:3015–3021
Maiuri F, Gallicchio B, Donati P, Carandente M (1987) The blood leukocyte count and its prognostic significance in subarachnoid hemorrhage. J Neurosurg Sci 31:45–48
McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT (2002) Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 51:1128–1134
McGirt MJ, Mavropoulos JC, McGirt LY, Alexander MJ, Friedman AH, Laskowitz DT, Lynch JR (2003) Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 98:1222–1226
Mesis RG, Wang H, Lombard FW, Yates R, Vitek MP, Borel CO, Warner DS, Laskowitz DT (2006) Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus 21:E4
Minami N, Tani E, Yokota M, Maeda Y, Yamaura I (1991) Immunohistochemistry of leukotriene C4 in experimental cerebral vasospasm. Acta Neuropathol 81:401–407
Nam DH, Kim JS, Hong SC, Lee WH, Lee JI, Shin HJ, Park K, Eoh W, Han DH, Kim JH (2001) Expression of interleukin-1 beta in lipopolysaccharide stimulated monocytes derived from patients with aneurysmal subarachnoid hemorrhage is correlated with cerebral vasospasm. Neurosci Lett 312:41–44
Neil-Dwyer G, Cruickshank J (1974) The blood leucocyte count and its prognostic significance in subarachnoid haemorrhage. Brain 97:79–86
Ng WH, Moochhala S, Yeo TT, Ong PL, Ng PY (2001) Nitric oxide and subarachnoid hemorrhage: elevated level in cerebrospinal fluid and their implications. Neurosurgery 49:622–626
Niikawa S, Hara S, Ohe N, Miwa Y, Ohkuma A (1997) Correlation between blood parameters and symptomatic vasospasm in subarachnoid hemorrhage patients. Neurol Med Chir 37:881–884
Oruckaptan HH, Caner HH, Kilinc K, Ozgen T (2000) No apparent role for neutrophils and neutrophil-derived myeloperoxidase in experimental subarachnoid haemorrhage and vasospasm: a preliminary study. Acta Neurochir 142:83–90
Pellettieri L, Carlson CA, Lindholm L (1981) Is the vasospasm following subarachnoidal hemorrhage an immunoreactive disease? Experientia 37:1170–1171
Pluta RM, Oldfield EH (2006) Sodium nitrite as a therapeutic agent for central nervous system diseases. Surg Neurol 66:5–7
Pluta RM, Thompson BG, Afshar JK, Boock RJ, Iuliano B, Oldfield EH (2001) Nitric oxide and vasospasm. Acta Neurochir Suppl 77:67–72
Pluta RM, Zauner A, Morgan JK, Muraszko KM, Oldfield EH (1992) Is vasospasm related to proliferative arteriopathy? J Neurosurg 77:740–748
Polin RS, Bavbek M, Shaffrey ME, Billups K, Bogaev CA, Kassell NF, Lee KS (1998) Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 89:559–567
Pradilla G, Thai QA, Legnani FG, Hsu W, Kretzer RM, Wang PP, Tamargo RJ (2004) Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits. Neurosurgery 55:1393–1399
Provencio JJ, Altay T, Smithason S, Moore SK, Ransohoff RM (2011) Depletion of Ly6G/C(+) cells ameliorates delayed cerebral vasospasm in subarachnoid hemorrhage. J Neuroimmunol 232:94–100
Provencio JJ, Fu X, Siu A, Rasmussen PA, Hazen SL, Ransohoff RM (2010) CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage. Neurocrit Care 12:244–251
Pyne-Geithman GJ, Morgan CJ, Wagner K, Dulaney EM, Carrozzella J, Kanter DS, Zuccarello M, Clark JF (2005) Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 25:1070–1077
Roy A, Rozanov C, Mokashi A, Daudu P, Al-mehdi AB, Shams H, Lahiri S (2000) Mice lacking in gp91 phox subunit of NAD(P)H oxidase showed glomus cell [Ca(2+)](i) and respiratory responses to hypoxia. Brain Res 872:188–193
Sabri M, Ai J, Macdonald RL (2011) Nitric oxide related pathophysiological changes following subarachnoid haemorrhage. Acta Neurochir Suppl 110:105–109
Sehba FA, Pluta RM, Zhang JH (2011) Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol 43:27–40
Sela S, Shurtz-Swirski R, Awad J, Shapiro G, Nasser L, Shasha SM, Kristal B (2002) The involvement of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation among cigarette smokers. Isr Med Assoc J 4:1015–1019
Stein SC, Levine JM, Nagpal S, LeRoux PD (2006) Vasospasm as the sole cause of cerebral ischemia: how strong is the evidence? Neurosurg Focus 21:E2
Tekkok IH, Tekkok S, Ozcan OE, Erbengi T, Erbengi A (1994) Preventive effect of intracisternal heparin for proliferative angiopathy after experimental subarachnoid haemorrhage in rats. Acta Neurochir (Wien) 127:112–117
Vieweg U, Schramm J, Urbach H (1999) Platelet-derived growth factor (PDGF-AB) like immune reactivity in serum and in cerebral spinal fluid following experimental subarachnoid haemorrhage in dogs. Acta Neurochir 141:861–865
Wang L, Shi JX, Yin HX, Ma CY, Zhang QR (2005) The influence of subarachnoid hemorrhage on neurons: an animal model. Ann Clin Lab Sci 35:79–85
Yamaguchi M, Zhou C, Nanda A, Zhang JH (2004) Ras protein contributes to cerebral vasospasm in a canine double-hemorrhage model. Stroke 35:1750–1755
Yang MF, Sun BL, Xia ZL, Zhu LZ, Qiu PM, Zhang SM (2003) Alleviation of brain edema by L-arginine following experimental subarachnoid hemorrhage in a rat model. Clin Hemorheol Microcirc 29:437–443
Yatsushige H, Yamaguchi M, Zhou C, Calvert JW, Zhang JH, Yatsushige H, Yamaguchi M, Zhou C, Calvert JW, Zhang JH (2005) Role of c-Jun N-terminal kinase in cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 36:1538–1543
Acknowledgment
I would like to acknowledge David Schumick for developing the illustration.
Financial Disclosure
This work was supported by a grant from the National Institutes of Health (K08-NS051350 J.J.P.) and the Cleveland Clinic Cerebrovascular Center (Institutional Support J.J.P.).
Conflicts of Interest Statement
I declare that I have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Provencio, J.J. (2013). Inflammation in Subarachnoid Hemorrhage and Delayed Deterioration Associated with Vasospasm: A Review. In: Zuccarello, M., Clark, J., Pyne-Geithman, G., Andaluz, N., Hartings, J., Adeoye, O. (eds) Cerebral Vasospasm: Neurovascular Events After Subarachnoid Hemorrhage. Acta Neurochirurgica Supplement, vol 115. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1192-5_42
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1192-5_42
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1191-8
Online ISBN: 978-3-7091-1192-5
eBook Packages: MedicineMedicine (R0)